DeepMed Research

Eastern Cooperative Oncology Group

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 2012-01-01

Employees: 51

Market Cap: -

Website: https://ecog-acrin.org

Clinical Trials

Tretinoin With or Without Fenretinide in Treating Patients With Dysplastic Nevus Syndrome

Phase 2

Completed

Conditions: Melanoma (Skin)

First Posted Date: 2004-08-26

Last Posted Date: 2023-06-18

Lead Sponsor: Eastern Cooperative Oncology Group

Target Recruit Count: 38

Registration Number: NCT00003601

Locations: 🇺🇸
University of Pennsylvania Cancer Center, Philadelphia, Pennsylvania, United States

Combination Chemotherapy in Treating Women With Breast Cancer

Phase 3

Completed

Conditions: Breast Cancer

First Posted Date: 2004-08-26

Last Posted Date: 2023-06-15

Lead Sponsor: Eastern Cooperative Oncology Group

Target Recruit Count: 2778

Registration Number: NCT00003519

Locations: 🇺🇸
USC/Norris Comprehensive Cancer Center, Los Angeles, California, United States
🇺🇸
Veterans Affairs Outpatient Clinic - Martinez, Martinez, California, United States
🇺🇸
University of Chicago Cancer Research Center, Chicago, Illinois, United States

and more 131 locations

Combination Chemotherapy After Surgery in Treating Patients With Cancer of the Esophagus or Stomach

Phase 2

Completed

Conditions: Esophageal Cancer
Gastric Cancer

First Posted Date: 2004-08-25

Last Posted Date: 2023-06-22

Lead Sponsor: Eastern Cooperative Oncology Group

Target Recruit Count: 55

Registration Number: NCT00003237

Locations: 🇺🇸
Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, United States
🇺🇸
New England Medical Center Hospital, Boston, Massachusetts, United States
🇺🇸
Medical College of Wisconsin, Milwaukee, Wisconsin, United States

and more 27 locations

Flutamide, Suramin, and Hydrocortisone in Treating Patients With Prostate Cancer

Phase 3

Completed

Conditions: Prostate Cancer

First Posted Date: 2004-08-24

Last Posted Date: 2010-11-09

Lead Sponsor: Eastern Cooperative Oncology Group

Registration Number: NCT00002881

Locations: 🇺🇸
Walter Reed Army Medical Center, Washington, District of Columbia, United States

Combination Chemotherapy in Treating Patients With Advanced Head and Neck Cancer

Phase 3

Completed

Conditions: Head and Neck Cancer

First Posted Date: 2004-08-24

Last Posted Date: 2013-06-21

Lead Sponsor: Eastern Cooperative Oncology Group

Registration Number: NCT00002888

Locations: 🇺🇸
Herbert Irving Comprehensive Cancer Center, New York, New York, United States
🇺🇸
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States
🇺🇸
Veterans Affairs Outpatient Clinic - Martinez, Martinez, California, United States

and more 84 locations

Piritrexim in Treating Patients With Advanced Cancer of the Urinary Tract

Phase 2

Completed

Conditions: Bladder Cancer
Transitional Cell Cancer of the Renal Pelvis and Ureter
Urethral Cancer

First Posted Date: 2004-08-11

Last Posted Date: 2023-06-22

Lead Sponsor: Eastern Cooperative Oncology Group

Target Recruit Count: 40

Registration Number: NCT00002914

Locations: 🇺🇸
Indiana University Cancer Center, Indianapolis, Indiana, United States
🇺🇸
Cleveland Clinic Cancer Center, Cleveland, Ohio, United States
🇺🇸
CCOP - Metro-Minnesota, Saint Louis Park, Minnesota, United States

and more 26 locations

Cetuximab, Chemotherapy, and Radiation Therapy for Operable Stage III or IV Head and Neck Cancer

Phase 2

Completed

Conditions: Head and Neck Cancer

Interventions: Biological: Cetuximab
Drug: Carboplatin
Drug: Paclitaxel
Radiation: Radiation therapy

First Posted Date: 2004-08-05

Last Posted Date: 2023-06-29

Lead Sponsor: Eastern Cooperative Oncology Group

Target Recruit Count: 74

Registration Number: NCT00089297

Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas

Phase 2

Completed

Conditions: Pancreatic Cancer

First Posted Date: 2004-08-04

Last Posted Date: 2023-06-15

Lead Sponsor: Eastern Cooperative Oncology Group

Registration Number: NCT00003810

Locations: 🇺🇸
Greater Baltimore Medical Center and Cancer Center, Baltimore, Maryland, United States
🇺🇸
New England Medical Center Hospital, Boston, Massachusetts, United States
🇺🇸
Johns Hopkins Oncology Center, Baltimore, Maryland, United States

and more 7 locations

Theophylline in Treating Patients With In Situ, Stage I, or Stage II Chronic Lymphocytic Leukemia

Phase 2

Completed

Conditions: Leukemia

First Posted Date: 2004-07-22

Last Posted Date: 2023-06-22

Lead Sponsor: Eastern Cooperative Oncology Group

Registration Number: NCT00003808

Locations: 🇺🇸
Johns Hopkins Oncology Center, Baltimore, Maryland, United States
🇺🇸
University of Pennsylvania Cancer Center, Philadelphia, Pennsylvania, United States
🇺🇸
Kimmel Cancer Center of Thomas Jefferson University - Philadelphia, Philadelphia, Pennsylvania, United States

and more 68 locations

Trastuzumab Plus Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer

Phase 2

Completed

Conditions: Lung Cancer

First Posted Date: 2004-07-19

Last Posted Date: 2013-06-21

Lead Sponsor: Eastern Cooperative Oncology Group

Registration Number: NCT00003881

Locations: 🇺🇸
Ireland Cancer Center, Cleveland, Ohio, United States
🇺🇸
Veterans Affairs Medical Center - Cleveland, Cleveland, Ohio, United States
🇺🇸
Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, United States

and more 68 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy